Switching between weight loss medicines: what to know
There is no dose conversion chart, because nobody has published one. Here’s what that actually means when a switch is being considered.
Weight loss injections vs tablets: how the options compare
Four licensed medicines, two delivery methods, and a lot of confusion. A factual comparison of what each one actually is.
Wegovy tablets: the oral version explained
Same medicine, different delivery, and a fairly demanding set of instructions. Here’s what the licence covers and what the trial measured.
Foundayo (orforglipron): the weight loss tablet explained
The UK became the first country in Europe to license it. Here’s what the regulator actually approved, and what the trials behind it measured.
Wegovy 7.2 mg: what the higher dose means
A higher maximum dose of semaglutide was licensed in the UK in 2026. Here’s what the regulator approved and what the trial behind it actually measured.
Who can get weight loss medication in the UK? NHS and private criteria explained
The licence says one thing, the NHS says another, and the two get confused constantly. Here’s who actually qualifies, and what a safe prescriber has to check.
What happens when you stop weight loss medication?
Appetite comes back when the medicine stops. Here’s what the trials found about regain, and why the plan for stopping matters as much as the plan for starting.
Side effects of weight loss medicines: what’s common, what’s rare and when to get help
Most of it is your gut adjusting, and it passes. A few things aren’t — here’s how to tell one from the other, and when to ring someone.
Mounjaro vs Wegovy: how do they compare?
Two weekly injections, endlessly compared and rarely explained properly. Here’s what the trials actually measured, side by side.